5 results on '"thymosin beta 15"'
Search Results
2. Th22 is the effector cell of thymosin β15-induced hair regeneration in mice
- Author
-
Nana Tao, Yuyuan Ying, Xie Xu, Qingru Sun, Yaoying Shu, Shiyu Hu, Zhaohuan Lou, and Jianli Gao
- Subjects
Thymosin beta 15 ,T helper 22 ,IL-22 ,Hair follicle ,Immune homeostasis ,Pathology ,RB1-214 - Abstract
Abstract Background Thymosin beta family has a significant role in promoting hair regeneration, but which type of T cells play a key role in this process has not been deeply studied. This research aimed to find out the subtypes of T cell that play key role in hair regeneration mediated by thymosin beta 15 (Tβ15). Methods Ready-to-use adenovirus expressing mouse Tmsb15b (thymosin beta 15 overexpression, Tβ15 OX) and lentivirus-Tβ15 short hairpin RNA (Tβ15 sh) were used to evaluate the role of Tβ15 in hair regeneration and development. The effect of Th22 cells on hair regeneration was further studied by optimized Th22-skewing condition medium and IL-22 binding protein (IL-22BP, an endogenous antagonist of IL-22, also known as IL-22RA2) in both ex vivo culture C57BL/6J mouse skin and BALB/c nude mice transplanted with thymus organoid model. Results The results show that Tβ15, the homologous of Tβ4, can promote hair regeneration by increasing the proliferation activity of hair follicle cells. In addition, high-level expression of Tβ15 can not only increase the number of Th22 cells around hair follicles but also accelerate the transformation of hair follicles to maturity. Consistent with the expected results, when the IL-22BP inhibitor was used to interfere with Th22, the process of hair regeneration was blocked. Conclusions In conclusion, Th22 is the key effector cell of Tβ15 inducing hair regeneration. Both Tβ15 and Th22 may be the potential drug targets for hair regeneration.
- Published
- 2024
- Full Text
- View/download PDF
3. Thymosin Beta 15 Alters the Spatial Development of Thymic Epithelial Cells.
- Author
-
Xu, Xie, He, Kai, Hoffman, Robert D., Ying, Yuyuan, Tao, Nana, Guo, Wenqin, Shen, Jiaman, Liu, Xi, Li, Meiya, Yan, Meiqiu, Lv, Guiyuan, and Gao, Jianli
- Subjects
- *
EPITHELIAL cells , *THYMOSIN , *CARRIER proteins , *T cells , *THYMOCYTES , *AXONS - Abstract
The thymus is the most sensitive organ under various pathophysiological conditions, such as aging, starvation, and infection. As a key stromal cell for T cell development, it is well-known that thymic epithelial cells (TECs) play an important role in the thymus response to the external environment. Thymosin beta 15 (Tβ15) is a G-actin binding protein secreted by TECs, it plays an important role in maintaining the dynamic balance of actin, angiogenesis, axonal formation, and wound healing, but the relationship between Tβ15 and TECs is not clear yet. Here, we show the impact of Tβ15 on the TEC's spatial development, as well as the T-cell differentiation and thymic output. As a result, TEC is the main effector cell of Tβ15 in the thymus. Tβ15 OX inhibits the chemotaxis of TECs to the medulla and subsequently blocks the positive selection of thymocytes from CD3+TCRβ+CD4+CD8+ double positive cells to CD3+TCRβ+CD4+CD8− single-positive (CD4SP) cells. Tβ15-knockdown accelerates the reticular differentiation of astral TECs and medullary TECs. Importantly, mice implanted with Tβ15-knockdown iTECs show high thymic output but low peripheral T cell maturity and activity. In a word, our results explain the role of Tβ15 on the differentiation and function of TECs and provide a new perspective for understanding the process of thymus development and degeneration. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
4. Thymosin Beta 15 Alters the Spatial Development of Thymic Epithelial Cells
- Author
-
Xie Xu, Kai He, Robert D. Hoffman, Yuyuan Ying, Nana Tao, Wenqin Guo, Jiaman Shen, Xi Liu, Meiya Li, Meiqiu Yan, Guiyuan Lv, and Jianli Gao
- Subjects
action binding protein ,reticular differentiation ,thymocytes ,thymosin beta 15 ,thymic epithelial cells ,Cytology ,QH573-671 - Abstract
The thymus is the most sensitive organ under various pathophysiological conditions, such as aging, starvation, and infection. As a key stromal cell for T cell development, it is well-known that thymic epithelial cells (TECs) play an important role in the thymus response to the external environment. Thymosin beta 15 (Tβ15) is a G-actin binding protein secreted by TECs, it plays an important role in maintaining the dynamic balance of actin, angiogenesis, axonal formation, and wound healing, but the relationship between Tβ15 and TECs is not clear yet. Here, we show the impact of Tβ15 on the TEC’s spatial development, as well as the T-cell differentiation and thymic output. As a result, TEC is the main effector cell of Tβ15 in the thymus. Tβ15 OX inhibits the chemotaxis of TECs to the medulla and subsequently blocks the positive selection of thymocytes from CD3+TCRβ+CD4+CD8+ double positive cells to CD3+TCRβ+CD4+CD8− single-positive (CD4SP) cells. Tβ15-knockdown accelerates the reticular differentiation of astral TECs and medullary TECs. Importantly, mice implanted with Tβ15-knockdown iTECs show high thymic output but low peripheral T cell maturity and activity. In a word, our results explain the role of Tβ15 on the differentiation and function of TECs and provide a new perspective for understanding the process of thymus development and degeneration.
- Published
- 2022
- Full Text
- View/download PDF
5. Thymosin beta 15A (TMSB15A) is a predictor of chemotherapy response in triple-negative breast cancer
- Author
-
D. M. Zahm, Jan Budczies, M K Mehta, E. Weiss, Manfred Dietel, S. Loibl, Ralf Kronenwett, Silvia Darb-Esfahani, Thomas Karn, M. Gehrmann, Hans Bojar, Carsten Denkert, F Khandan, Beyhan Ataseven, Achim Rody, Jan C. Brase, and G. von Minckwitz
- Subjects
Oncology ,Cancer Research ,medicine.medical_specialty ,Receptor, ErbB-2 ,Breast Neoplasms ,triple negative ,predictive factor ,breast cancer ,Breast cancer ,Cell Line, Tumor ,Internal medicine ,Humans ,Medicine ,RNA, Messenger ,skin and connective tissue diseases ,Molecular Diagnostics ,Triple-negative breast cancer ,Reverse Transcriptase Polymerase Chain Reaction ,business.industry ,Gene Expression Profiling ,thymosin beta 15 ,Estrogen Receptor alpha ,Thymosin ,medicine.disease ,Clinical trial ,Logistic Models ,Clinical Trials, Phase III as Topic ,Immunology ,Female ,Thymosin beta 15a ,Receptors, Progesterone ,business ,Estrogen receptor alpha ,hormones, hormone substitutes, and hormone antagonists ,Chemotherapy response ,neoadjuvant chemotherapy - Abstract
Background: Biomarkers predictive of pathological complete response (pCR) to neoadjuvant chemotherapy (NACT) of breast cancer are urgently needed. Methods: Using a training/validation approach for detection of predictive biomarkers in HER2-negative breast cancer, pre-therapeutic core biopsies from four independent cohorts were investigated: Gene array data were analysed in fresh frozen samples of two cohorts (n=86 and n=55). Quantitative reverse transcription polymerase chain reaction (qRT–PCR) was performed in formalin-fixed, paraffin-embedded (FFPE) samples from two neoadjuvant phase III trials (GeparTrio, n=212, and GeparQuattro, n=383). Results: A strong predictive capacity of thymosin beta 15 (TMSB15A) gene expression was evident in both fresh frozen cohorts (P
- Published
- 2012
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.